Introduction {#S1}
============

Secondary infertility is the most common type of female infertility worldwide, often because of endometrium injuries and subsequent intrauterine adhesion (IUA). It poses a great threat to female physical and mental health ([@B13]; [@B57]; [@B16]). The uterus tissue is made up of three layers, among which the endometrium, composed of functional and basal layers, is the inner-most layer. The functional endometrium is the site of embryo implantation and is regulated by changes in ovarian hormones. The basal endometrium regenerates and repairs the endometrium wound after menstruation, and forms the functional layer again, possibly via the intrinsic endometrial cells, such as endometrial epithelial and stromal cells, endometrial stem cells and perivascular cells. They may secrete bioactive molecules, growth factors, hormones and contribute to angiogenesis and endometrium regeneration after uterus injuries. The pathological changes include endometrial fibrosis and scarring, loss or thinning of endometrium due to different degrees of damage to the basal layer of endometrium, IUA between anterior and posterior walls, and shrinkage of uterine cavity ([@B11]). Microscopic observation shows gland atrophy, lack of vascular stromal tissues and hypoxia and anemia microenvironment in the adhesion areas ([@B18]; [@B21]). Present clinical techniques, such as hormonal therapy, surgical synechiotomy and subsequent intrauterine device (IUD) implantation, show unsatisfactory outcomes, recurrent adhesion and secondary infection during the treatment of IUA, also known as Asherman's syndrome ([@B3], [@B4]; [@B43]). The surgical synechiotomy helps surgeons release the adhesive fibrosis with blunt-end scissors. However, the postoperative recovery shows a huge variation among different patients due to adhesion severity. Some of them even experienced greater adhesion recurrence. Hormonal therapy works effectively after surgical release of IUA. Nevertheless, it is still hard to confirm a suitable medication dosage and route due to the short half-life period, low water solubility and big differences in response. As for the IUDs, they only function as physical barriers. However, they can barely induce regenerative process and thus yield low endometrium recovery. Therefore, it is urgent and vital to find alternative treatments for Asherman's syndrome ([@B16]).

The development of biomimetic tissue engineering provides an alternative therapy that may increase the success of uterine regeneration and reproductive capacity ([@B9]). Biomaterial is an important factor in the tissue engineering because it can provide structural support that mimics native endometrium tissues and uterine organs ([@B68]). In addition, some biomedical materials are characterized by physical, chemical and biological properties that are closely related to uterus regeneration. The other two factors in the tissue engineering are supporting cells and bioactive molecules. They both facilitate cellular and extracellular signaling, nutrient transport, stem cell recruitment, proliferation and differentiation. Biomaterials can release drugs, growth factors, small molecules and other bioactive compounds in a controlled style, with or without cell loading and modification. Recent researches have shown that, in addition to traditional biomaterial based uterus regeneration, combination and modification of cells and biomaterials, such as cell sheets, cell-scaffold interfaces, surface-functionalized scaffolds and decellularization of biological tissues may also display functional or structural advantages and repair injured uterus to different extents by inducing biomimetic changes and recreating regenerative microenvironment ([@B36]). Therefore, we comprehensively reviewed current advances in the biological interactions and applications of different types of biomimetic endometrium and uterus scaffolds for female infertility treatment and compared their potential therapeutic effects in this review ([Figure 1](#F1){ref-type="fig"}).

![Schematic illustration of different biomimetic endometrium interfaces manufacturing.](fbioe-08-00153-g001){#F1}

Stem Cell Sheet Engineering in the Endometrium Regeneration {#S2}
===========================================================

Cell sheet engineering (CSE) is an emerging technique for cell transplantation using temperature-responsive culture dishes to repair damaged organs or tissues and has displayed potential capacity in the tissue regeneration ([@B44]). Cell sheets naturally have two sides: apical and basal interfaces. Both of them contained abundant extracellular matrix (ECM) necessary for providing maximum strength and adherence to the host tissue surface ([@B59]). CSE includes cell culture in thermo-sensitive plates that develop compact cell sheets which detach with temperature drop ([@B26]). As a major advantage, this technology permits maintenance of growth factors, ECM proteins, and other bioactive cytokines because cells are detached spontaneously from the culture plates without the need for enzymatic procedures and proteolytic treatments. The endometrial epithelial cell is a local cell type in the endometrium of uterus. It is suitable to seek these cells for cell engineering ([@B29]). However, in real practices, the collection of endometrial cells is not a recommended option because it is hard to collect adequate quantity of endometrial cells from the uterus and collection may also be interfered by certain inflammatory or contagious diseases, apart from the harm out of invasive procedures ([@B38]). Stem cell sheet engineering (SCSE) gradually becomes an important research direction due to the minimal invasiveness, autologous tissue supply, multi-differentiation potential, high proliferation, growth factor secretion and signaling transduction of stem cells ([@B54]; [@B23]; [@B25]).

Oral mucosal epithelial cell sheets (OMECS) were applied in IUA prevention and subsequent infertility as a novel regenerative technique ([@B30]). OMECS were obtained by minimal invasiveness surgery from oral mucosal epithelial tissues and were composed of stratified squamous epithelial cells. Therefore, cell collection was easy and harmless. OMECS successfully retained the luminal structure of the uterine and prevented re-adhesion occurrence by controlling neutrophil infiltration.

Although the thermo-responsive approach is very effective, it is further modified and improved due to the high cost, and time-consuming properties. [@B56] developed a new and user-friendly method by adding ascorbic acid into adipose-derived stem cells (ADSC) to construct cell sheets. ADSCs are widely used for tissue engineering due to their self-renewable, proliferative and regenerative characteristics ([@B39]; [@B50]). After *in vitro* culture, ADSCs secreted and were surrounded by ECM proteins. The expansion of cell sheet constructs further increased expression of many ECM proteins and trophic growth factors including vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF) ([@B66]). The implantation of ADSC sheets in the damaged rat uterus prevented luminal stenosis or scar formation by decreasing transforming growth factor-β (TGF-β) and collagen I levels, similar to sham operation. The cell sheets stimulated blood vessel development and endometrial gland proliferation in the endometrial stromal layer. In contrast, the blank control group displayed hyperplastic fibrosis. ADSCs were successfully differentiated into endometrial stromal cells under uterine microenvironment. The findings indicated implantable ADSC sheets attached closely to the injured uterine and facilitated endometrium repair by providing a biomimetic trophic support that was vital for cell proliferation. Natural cell sheet constructs did not induce any inflammation and thus caused insignificant scar formation ([@B56]). SCSE is very beneficial for uterus repair by secreting growth factors and nutritional proteins. However, the cell viability remains a serious question *in vivo* and requires better scaffold support for long-term survival ([Table 1](#T1){ref-type="table"}).

###### 

Fabrication and functions of different biomimetic scaffolds for endometrium and uterus regeneration.

  **Interface type**        **Cells**   **Construct technique**                                               **Biological effects**                                                                   **Model**                **Author/year**
  ------------------------- ----------- --------------------------------------------------------------------- ---------------------------------------------------------------------------------------- ------------------------ -----------------
  Cell sheet                OMEC        Thermo-sensitive plate                                                Maintenance of luminal structure, little neutrophil infiltration                         F344/NJcl-rnu/rnu rats   [@B30]
  Cell sheet                ADSC        Fusion of ascorbic acid                                               Trophic factor release, angiogenesis, no inflammation                                    SD rats                  [@B56]
  Cell-scaffold             dEMSC       *In vitro* decidualization and encapsulation                          Shortening recovery time, better mimicking native tissues and stiffness                  C57BL/6 mice             [@B28]
  Cell-scaffold             En-PSC      CYR61-transfected cell loading                                        Increasing the blood vessel density and angiogenic growth factor                         SD rats                  [@B33]
  Cell-scaffold             BMSC        Cell seeding on collagen                                              Stem cell recruitment and microvasculature regeneration                                  SD rats                  [@B15]
  Cell-scaffold             BMSC        Encapsulation by thermo-responsive gelation of PF-127 and vitamin C   Redox homeostasis, endometrial thickness recovery                                        SD rat                   [@B65]
  Cell-scaffold             BMSC        Solvent casting and particle leaching                                 Improving BMSC proliferation and differentiation, *in situ* retention, vascularization   SD rats                  [@B61]
  Cell-scaffold             BMNC        Cell seeding on collagen                                              Downregulating ΔN p63 expression and inhibiting endometrial quiescence                   Human patients           [@B71]
  Cell-scaffold             UCMSC       Cell seeding on collagen                                              Endometrial proliferation, differentiation and vascularization                           Human patients           [@B8]
  Cell-scaffold             UCMSC       Cell mixture with collagen fibers                                     Collagen deposition and reduced scar formation                                           SD rats                  [@B64]
  Cell-scaffold             UCMSC       Freeze-drying and thermal treatment crosslinking                      Increasing estrogen, progesterone and growth factor levels; epithelial reconstruction    SD rats                  [@B62]
  Cell-scaffold             hESC        Cell seeding on collagen                                              High differentiation ratio                                                               SD rats                  [@B55]
  Functionalized scaffold   /           Fermentation and lipholization                                        Vascularization and endometrium maturation                                               SD rats                  [@B5]
  Functionalized scaffold   /           CBD-modified bFGF                                                     Target delivery of bFGF and prolonging retention time                                    SD rats                  [@B34]
  Functionalized scaffold   /           CBD-modified VEGF                                                     Activation of MMP and remodeling of ECM                                                  SD rats                  [@B35]
  Functionalized scaffold   /           Droplet microfluidics                                                 Steady bFGF release, no side effects or excessive loss of burst delivery                 SD rats                  [@B6]
  Functionalized scaffold   /           Sol-gel transition                                                    Increasing autophagy by inhibition of mTOR signaling pathway                             SD rats                  [@B63]
  Functionalized scaffold   /           Lipholization and rotary evaporation                                  Increasing vascularity by activation of ERK1/2 pathways                                  SD rats                  [@B67]
  Functionalized scaffold   /           Ultraviolet irradiation and gel formation                             Increasing regeneration-related cytokines and prolonging secretome retention             SD rats                  [@B37]
  Decellularized scaffold   /           Aortic perfusion with detergents                                      Preservation of native ECM and vasculature                                               SD rats                  [@B42]
  Decellularized scaffold   /           Decellularization by detergents or high hydrostatic pressure          Collagen retention, uterine tissue repair combined with cell migration                   SD rats                  [@B52]
  Decellularized scaffold   /           Perfusion with Triton, dimethyl sulfoxide or sodium deoxycholate      Recellularization of the scaffold and infiltration of regional stem cells                Lewis rats               [@B22]
  Decellularized scaffold   /           Whole organ perfusion                                                 Successful recellularization by human side population stem cells                         /                        [@B7]
  Decellularized scaffold   /           Perfusion with 0.25% and 0.5% SDS and preservation in 10% formalin    Biomimetic mechanical, structural, and angiogenic characteristics                        Wistar rats              [@B12]
  Decellularized scaffold   /           Perfusion with SDS                                                    Orientation of smooth muscle layers and ECM                                              SD rats                  [@B41]

OMEC, oral mucosal epithelial cell; ADSC, adipose-derived stem cell; dEMSC, decidualized endometrial stromal cell; En-PSC, endometrial perivascular cell; CYR61, cysteine-rich angiogenic inducer 61; BMSC, bone marrow mesenchymal stem cell; BMNC, bone marrow mononuclear cell; UCMSC, umbilical cord derived mesenchymal stem cell; hESC, human embryonic stem cell; CBD, collagen binding domain; bFGF, basic fibroblast growth factor; MMP, matrix metalloprotein; ECM, extracellular matrix; mTOR, mammalian target of rapamycin; ERK 1/2, extracellular regulated protein kinases 1/2; SDS, sodium dodecyl sulfate; SD, Sprague Dawley. "/" means "not applicable."

Cell-Scaffold Interface-Based Endometrium Regeneration {#S3}
======================================================

Biomaterials provide structural and mechanical support for tissue repair by helping to restore the architecture and functionality of the wounded tissues. They may also partially mimic native environment by inducing physicochemical changes and simulating changes of growth factors, signaling molecules and extracellular vesicles like cellular materials ([@B27]; [@B36]). However, it is insufficient to simply use scaffold biomaterial for repairing large uterus defects ([@B62]). Several factors should be considered carefully, such as vascularization, native cell recruitment, and scar inhibition ([@B45]). Cell seeding on the scaffold materials increases biological functions by prolonging cell survival and stimulating cell proliferation, differentiation and vascularization ([@B19]).

[@B28] also used decidualized endometrial stromal cells (dEMSCs) encapsulated in hyaluronic acid (HA) hydrogel in a murine uterine infertility model. At 2 weeks after injury, the fibrous tissues were decreased and the endometrium thickness was increased. Some embryonic markers, including desmin, CD44, and platelet endothelial cell adhesion molecule, were highly expressed and secreted in the functional regenerated endometrium. Successful implantation of transferred embryos was followed by normal development and live birth of offspring after the dEMSC-loaded HA hydrogel treatment. The selection of bioprocessed isotopic cells shortened the recovery time significantly compared to bone marrow mesenchymal stem cells (BMSCs) or human embryonic stem cell (hESC)-derived endometrium-like cells. In addition, HA appeared to be very suitable for the repair of endometrium where plenty of hyaluronidase could degrade HA. Furthermore, the limiting mobility of cross-linkage with porosity allowed seeding cells to maintain in the injured site and provided the ideal scaffold stiffness for endometrium regeneration.

[@B33] focused on the restoration of angiogenesis and inhibition of scar tissue formation in the selection of cell types for uterine repair. Endometrial perivascular cells (CD146 + platelet derived growth factor receptor (PDGFR) β +) (En-PSCs) worked similarly as stem cells in the endometrial layer. Cysteine-rich angiogenic inducer 61 (CYR61) contributed to vascular formation ([@B72]). They thus designed a CYR61-transfected En-PSC-loaded collagen scaffold and found it significantly increased the blood vessel density because the scaffold stimulated the release of angiogenic factors from the ECM and accelerated an overall process of neovascularization *in vivo*.

Apart from endometrium-derived cells, BMSCs were largely used for endometrium and uterus regeneration due to their convenient isolation, abundant resources and reparative potential ([@B60]). [@B15] transplanted BMSC-loaded collagen scaffolds to the wounded rat uterine horn. BMSCs were mainly recruited at the regenerated basal membrane of the endometrium. The injured tissue next to the cell-scaffold composite showed high expression levels of basic FGF (bFGF), insulin-like growth factor 1 (IGF-1), TGF-β1, VEGF and prominent microvasculature regeneration. BMSC-loaded scaffold recovered the receptive ability of the new endometrium. [@B65] reported that BMSCs were encapsulated by thermo-responsive gelation of pluronic F-127 (PF-127) and vitamin C, which added to the membrane stability. In addition, vitamin C, as a prominent antioxidant, downregulated tumor necrosis factor α (TNF-α) and interleukin 6 (IL-6) secretion, maintained redox homeostasis and facilitated a pro-regenerative tendency by increasing interleukin 10 (IL-10) level ([@B17]; [@B48]). The BMSC/PF-127 + vitamin C hydrogel recovered endometrial thickness and decreased the fibrotic regions of the stromal tissues of endometrium. [@B61] loaded BMSCs on a synthetic Poly(glycerol sebacate) (PGS) scaffold which potentially recovered different deformations of soft tissues in various dynamic conditions without external irritations. They compared different cell-scaffold constitutes, including BMSC/collagen, BMSC/poly(lactic-co-glycolic acid) (PLGA), and BMSC/PGS. They found PGS showed a stronger improvement in proliferation and endometrial differentiation of BMSC. Furthermore, *in vivo* studies showed a longer *in situ* retention time of BMSC and higher areas of vascularization from PGS-based scaffold. It was vital for successful recuperation of damaged uterus tissues. Bone marrow mononuclear cells (BMNCs) are derived from hematopoietic stem cells in the bone marrow and develop in the bone marrow. [@B71] applied collagen scaffolds loaded with BMNCs in patients of Asherman's syndrome by downregulating ΔNp63 expression and inhibiting endometrial quiescence and other related pathological changes. BMNC-loaded collagen scaffolds restored estradiol (E2) stimulation and reaction to functional endometrium growth. Five patients were successfully pregnant and delivered live births.

Umbilical cord derived mesenchymal stem cells (UCMSCs) have displayed their merits in adequate sources, pain-free acquisition and excellent proliferation capacity ([@B31]). UCMSCs were loaded on collagen scaffolds and transferred to injured uterus of human patients. [@B8] confirmed an improvement in endometrial proliferation, differentiation and neovascularization following the implantation of this cell-scaffold mixture without introducing exogenous DNA to the regenerated endometrium. Furthermore, most babies were born without any obvious birth defects or placenta complications. [@B64] also focused on UCMSCs and their potentials for reducing scar formation. They found UCMSCs mixed with gelatinous degradable collagen fibers showed prominent angiogenesis and insignificant scarring in the injured site. The cell-scaffold composite degraded collagen in scarring areas by increasing matrix metalloprotein 9 (MMP-9), FGF-2 and VEGF and led to angiogenesis and endometrial cyclic regeneration. [@B62] found UCMSC-loaded collagen scaffold reduced cellular apoptosis and improved human endometrial stromal cell via a paracrine route. The scaffold barely caused any inflammation because it contributed to collagen remodeling in the reconstructed endometrium. In addition, UCMSC-loaded collagen scaffold induced early rapid re-epithelialization by increasing proliferation and cytokeratin expression levels, which were vital for subsequent endometrium repair after damages. The scaffold subsequently elevated circulating estrogen and progesterone levels as well as growth factor expression.

[@B55] loaded hESC-derived endometrium-like cells on collagen scaffolds to repair uterine horn damages. They innovatively induced endometrial differentiation by adding endometrial stromal cells and achieved a differentiation rate of above 80%, 2.2 fold higher than the cytokine induction. Large quantities of endometrium-like cells improved endometrial function and development by simulating an *in vivo* endometrium stem cell niche, and secreted growth factors that modulated the effects of estrogen and progesterone-driven basal layer repair. Cell loading on the scaffolds improves the biological activity of biomaterials and keeps the physiochemical properties to support the mechanical stability of tissue regrowth ([Table 1](#T1){ref-type="table"}).

Surface Functionalized Scaffold-Based Endometrium Regeneration {#S4}
==============================================================

In addition to direct cell loading in the scaffolds, many strategies are focused on the surface or structure modification for better biocompatibility and stronger absorption for cell attachment and delivery of bioactive growth factors, hormones and extracellular vesicles ([@B32]; [@B53]). Bacterial cellulose (BC) is a biocompatible and water adsorbable bacteria scaffold. It was used in bone, vessel and nerve repair ([@B24]; [@B58]; [@B49]). [@B5] improved the BC porosity by supplementing silk fibroin (SF) and stromal cell derived factor 1 α (SDF-1α). The functionalized nanoscaffold delivered SDF-1α from SF-BC membrane carrier and induced uterine cell migration *in vitro* and increased endometrium thickness and number of fetuses. They explained the effects of functionalized BC scaffold as it specifically improved migration and regeneration of glandular epithelial cells, which were vital for decidualization, implantation, and embryo development. In addition, the scaffold significantly increased arterial formation. These findings were mainly due to the dual effects of SDF-1α loaded SF-BC scaffolds: vascularization and endometrium maturation.

[@B34] designed a collagen scaffold loaded with collagen binding domain (CBD)-modified bFGF. This combination significantly reduced the random diffusion of bFGF *in vivo* and increased target delivery at the endometrium. The recombinant proteins were transported in a location specific style with collagen and kept the effective concentration in the injured area. The complex scaffold induced high neovascularization, muscle fiber alignment and thick endometrium layers, which was very effective to tissue repair. However, the embryo rate was low in this study, indicating the functional recovery of the endometrium was not achieved.

Similarly, [@B35] loaded CBD/VEGF on the collagen scaffold for improving angiogenesis and endometrium re-epithelialization. They compared different release manners of VEGF, including CBD and native injection, in the regeneration of full-thickness injury of rat uterus. The vascular tissue growth provided the scar areas with nutrients and oxygen. Furthermore, target release of VEGF activated MMP and initiated ECM remodeling by increasing inflammatory cells at early stages. The findings showed a 31.2% improvement of pregnancy rate in the application of CBD/VEGF collagen (50.0%) compared with local VEGF injection only (18.8%).

[@B6] invented a new method for bFGF controlled release because of the porous surface and external--internal based open porous architecture. They fabricated the bFGF-loaded porous scaffold from microfluidic droplets. The adjustable porous design could be controlled precisely. It facilitated steady bFGF release and avoided side effects and excessive loss of burst delivery in high concentrations. The long-term reparative performance was excellent due to adhesion inhibition, vascular promotion and induction for endothelial cell migration by this bFGF-loaded porous scaffold.

[@B63] fabricated a temperature sensitive hydrogel loaded by keratinocyte growth factor (KGF), a kind of reparative factor. The scaffold allowed controlled release and prolonged retention of the drug in the injured uterus. They found KGF-modified hydrogel scaffold facilitated cell autophagy by inhibition of mammalian target of rapamycin (mTOR) signaling pathway and improved CD31 expression levels, endothelial migration and proliferation of endometrial glandular epithelial cells and luminal epithelial cells. Functional epithelial repair was due to restoration of appropriate micro-milieu by reducing inflammation and immune responses ([@B20]; [@B70]).

Similarly, [@B67] fabricated 17β-E2-loaded heparin-poloxamer hydrogel and found it significantly decreased endoplasmic reticulum (ER) stress-related apoptosis. E2 sustained release effectively reduced fibrotic tissue areas and stimulated vascularity to provide more nutrients, oxygen, and hormones to the injured tissues, supported by activated extracellular regulated protein kinases 1/2 (ERK1/2) pathways that closely participated in some cellular activities, such as proliferation, viability, and motility ([@B47]; [@B40]).

In addition to bioactive proteins, some researches focused on the secreted extracellular vesicles from stem cells for uterus repair ([@B69]; [@B1]). [@B37] innovatively created stem cell secretome modified-HA hydrogel that increased release of a number of regeneration-related growth factors, such as epidermal growth factor (EGF), FGF, IGF-1, and IGF binding protein (IGFBP). The crosslinked HA gel served as a carrier and prolonged the *in vivo* retention time of stem cell secretome, thus leading to thicker endometrium and more glands compared to gel application only. Nano-scale functionalization of endometrium scaffolds mimics the natural environment, provides steady release of bioactive molecules and transmits signaling from extracellular vesicles in the process of uterus regeneration ([Table 1](#T1){ref-type="table"}).

Decellularized Biomimetic Scaffolds for Severe Uterine Injury Regeneration {#S5}
==========================================================================

Decellularized scaffolds are one of the alternatives for treatment of severe uterine injury because of their biocompatibility compared with synthetic material ([@B10]). These scaffold increased pregnancy and birth rate initially at the cost of long-term immunosuppressive therapy when scientists attempted in whole-organ transplantation in the early stage ([@B2]). However, it ignited hope for decellularization of biomimetic scaffolds for severe uterine injury repair. [@B42] fabricated decellularized uterine matrix scaffold from rat uterus by aortic perfusion with detergents. The scaffold provided not only mechanical support for uterine but also vascular architecture for blood perfusion. In addition, it induced recellularization, uterus regeneration and high pregnancy rate, close to the uninjured uterus. [@B52] used different methods for decellularization of the uterine matrix from rat uterus by sodium dodecyl sulfate (SDS) or high hydrostatic pressure (HHP), and found the latter better preserved ECM and was more efficient in cell removal. The HHP method also avoided collagen denaturation and reduction of protein contents. Interestingly, these two methods yielded entirely different manners of structural repair. In the SDS group, the repair mode was regeneration of tissue from native uterine tissue under the decellularized ECM. Nevertheless, cell migration and tissue restoration were combined as a unit in the HHP group. [@B22] created a uterine patch from rat uterus using perfusion method for scaffold decellularization and found the scaffold was biocompatible after recellularization *in vivo*. However, in their studies, the functional regeneration of the uterus was failed due to low pregnancy rates.

[@B7] employed decellularization and recellularization technique in the fabrication of a scaffold from porcine uterus and displayed the excellent vascular network in the ECM after recellularization by human side population stem cells. Similarly, [@B12] reported a whole-organ perfusion decellularization method for production of scaffold from ovine uterus and implanted its segments into rats. The scaffold successfully retained the vascular structure after decellularization and started recellularization in the endometrium and myometrium after implantation, potentially due to homing of the circulating and local stem cells. In addition, the excellent biomechanical properties guaranteed uterine regeneration for a long term *in vivo*. [@B41] found orientation in the smooth muscle cells and ECM was a vital factor of correct tissue topology and functional uterine regeneration by a decellularized scaffold from rat uterus. These researches indicate that decellularized biomaterials are helpful to functional uterus regeneration, due to their biocompatibility, regulation of cell survival and homing, and topological support ([Table 1](#T1){ref-type="table"}).

Discussion {#S6}
==========

Currently, there are no ideal treatments for severe IUA. Surgical release, hormone application or IUDs show their defects, respectively, such as failure in complete lysis and dosage control, and mismatch of IUD size ([@B51]). Thus, they cannot fully repair injured endometrium and uterus. Regenerative medicine by tissue engineering offers plenty of alternative choices that may heal the wound and repair the injuries by structurally and biologically mimicking the native organ and environment ([@B46]). Recent development in various endometrium and uterus scaffolds shows promising outcomes in regard to morphological and functional recovery as well as pregnancy rates. Cell tissue engineering mainly includes cell sheets engineering and cell-scaffold interfaces. CSE is suitable for providing ECM-like elements and maintaining activity of different cytokines and growth factors. Nevertheless, it may not prolong cell proliferation and retention without appropriate scaffold materials. Therefore, surface loading of different cells on the scaffolds is widely under investigation based on *in vivo* studies that have shown rapid re-epithelialization, formation of endometrium stem cell niche and hormone-driven basal layer regeneration. In addition to cell-related engineering, structural functionalization is very important and is studied extensively. Supporting scaffold materials are composed of synthetic and natural scaffolds. In this review, we discussed surface-functionalized scaffolds and decellularized scaffolds out of biological tissues. Generally, they should exert positive influences on cellular viability, including cell proliferation, attachment and differentiation. Scaffold functionalization may contribute to endometrium repair by facilitating bioactive factor release, such as growth factors, extracellular vesicles, and other signaling molecules. Decellularization of biological tissues provides ideal collagen matrix. At the same time, it should not introduce external cellular components or cause immune rejection. However, partial cell residuals remain a non-negligible issue that prevents translational application of this technique ([@B14]). Therefore, these different technological approaches to endometrium regeneration by tissue engineering have their merits and shortcomings that wait for further researches and investigation on possible solutions and improvement.

Conclusion {#S7}
==========

In conclusion, there are still few efficient strategies for uterus repair in spite of current clinical solutions. Bioengineering techniques provide fresh alternatives for the traditional surgical intervention, hormone therapy and IUD implantation. The application of cell tissue constructs, cell-scaffold complex, micro- or nano- scale material release and their combination significantly enriches the therapeutic category and improves the structural and functional regeneration of injured endometrium and uterus. Future directions should be focused on the combined studies concerning cell biology and scaffold topology. Neither cells nor scaffolds alone display full recovery of endometrium and uterus and sometimes lead to low pregnancy rates. The dynamic integration of these two elements is vital for biomimetic reconstruction of physiological uterus from both structural and functional perspectives. The balanced immune milieu and angiogenic environment significantly promote tissue regeneration and organ repair. Overall, these translational approaches have enormous potential in the treatment of female infertility in the future clinical practice.
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